|
2025
|
P/S
|
Promoting public awareness of non-alcoholic steatohepatitis (NASH) with liver fibrosis and treatm... |
|
|
Invention
|
Methods for treating a fatty liver disease. The present disclosure provides a method of treating ... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of patients
with non-alcoholic steatohepatitis (NA... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of patients with non-alcoholic steatohepatitis (NAS... |
|
|
P/S
|
Licensing services, namely, licensing of pharmaceutical intellectual property rights to third par... |
|
2024
|
Invention
|
Solid forms of 2-(3,5-dichloro-4-((5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yl)oxy)phenyl)-3,5-di... |
|
|
Invention
|
Biomarkers for treating liver disorders with thr-b agonists and related uses.
The present disclo... |
|
|
Invention
|
Biomarkers for treating liver disorders with thr-β agonists and related uses. The present disclos... |
|
2023
|
Invention
|
Method of synthesizing thyroid hormone analogs and polymorphs thereof.
The disclosure describes ... |
|
|
Invention
|
Method of synthesizing thyroid hormone analogs and polymorphs thereof. The disclosure describes m... |
|
|
P/S
|
Financial administration of pharmaceutical reimbursement programs Providing patient education pro... |
|
|
Invention
|
Methods of treating liver disorders or lipid disorders with a thr-beta agonist.
The present inve... |
|
|
Invention
|
Novel thr beta analogs and uses thereof.
Described herein are compounds of formula I:
Describe... |
|
|
Invention
|
Thr beta analogs and uses thereof. Described herein are compounds of formula I: (I), and pharmace... |
|
2022
|
Invention
|
Methods of synthesizing thyroid hormone analogs and polymorphs thereof.
The disclosure describes... |
|
|
Invention
|
Resmetirom for reducing liver volume.
The present disclosure describes a method of reducing live... |
|
|
Invention
|
Resmetirom for reducing liver volume. The present disclosure describes a method of reducing liver... |
|
|
Invention
|
Combination therapies comprising targeted therapeutics.
The present invention provides pharmacol... |
|
|
Invention
|
Targeted therapeutics.
The present invention provides pharmacological compounds including an eff... |
|
|
Invention
|
Therapeutic combinations of rosuvastatin and resmetirom for the treatment of liver disorders or l... |
|
2021
|
Invention
|
Methods for preparing pyridazinone derivatives.
The disclosure describes a method of preparing p... |
|
|
Invention
|
Process for the preparation of 6-(4-nitro-phenoxy)-2h-pyridazin-3-one and 6-(4-amino-phenoxy)-2h-... |
|
|
Invention
|
Methods of treating liver disorders or lipid disorders with a thr-beta agonist. The present inven... |
|
2020
|
Invention
|
Methods of synthesizing thyroid hormone analogs and polymorphs thereof. The disclosure describes ... |
|
|
Invention
|
Methods of treating neurological diseases and disorders.
The present invention is directed to co... |
|
2018
|
Invention
|
Targeted therapeutics. The present invention provides pharmacological compounds including an effe... |
|
|
Invention
|
Combination therapies comprising targeted therapeutics. The present invention provides pharmacolo... |
|
|
Invention
|
Targeted therapeutics. e.ge.g., therapeutic, diagnostic, and imaging) including the compounds. Th... |
|
|
Invention
|
Compositions and methods for treating systemic lupus erythematosus.
The present invention is dir... |
|
2017
|
Invention
|
Hsp90 inhibitor drug conjugates.
The present invention provides Hsp90 drug conjugates (HDCs) com... |
|
|
Invention
|
Hsp90 inhibitor drug conjugates. The present invention provides Hsp90 drug conjugates (HDCs) comp... |
|
2014
|
Invention
|
Compositions and methods for modulating c-rel-dependent cytokine production. The present inventio... |
